Clinical Trials Browser

Phase 2 × Lamivudine × Gastrointestinal × Clear all

NCT03144804 2024-06-06

A Phase 2 Study of Lamivudine in Patients With p53 Mutant Metastatic Colorectal Cancer

Phase 2 Completed

36 enrolled 11 charts

Gastrointestinal

Colorectal Neoplasms